StimCell Energetics Inc. Signs Marketing Agreement with Think Ink Marketing
VANCOUVER, BC / ACCESSWIRE / January 8, 2025 / StimCell Energetics Inc. (OTC PINK:STME) ("StimCell", or the "Company") a biotech...
Year: 2025
The 2025 Black Book of Physician Practice Management Technology Released: A Competitive Intelligence Report
Free to participants in the 2025 survey of PM software, this comprehensive report offers critical insights into trends, developments, and...
BioHarvest Issues Shareholder Letter and Provides Corporate Update
Vancouver, British Columbia and Rehovot, Israel--(Newsfile Corp. - January 8, 2025) - BioHarvest Sciences Inc., (NASDAQ: BHST) (CSE: BHSC) (FSE:...
The 2025 Black Book of Physician Practice Management Technology Released: A Competitive Intelligence Report
Free to participants in the 2025 survey of PM software, this comprehensive report offers critical insights into trends, developments, and...
Jaguar Health Presenting January 13 at Lytham 2025 Investor Healthcare Summit & January 14 at Biotech Showcase
SAN FRANCISCO, CA / ACCESSWIRE / January 8, 2025 / Jaguar Health, Inc. (NASDAQ:JAGX) today announced that Lisa Conte, the...
Champions Oncology Enhances Clinical Bioanalytical Services Portfolio with New Technology and Additional Leadership
HACKENSACK, NJ / ACCESSWIRE / January 8, 2025 / Champions Oncology, Inc. (NASDAQ:CSBR), a leading technology-enabled oncology research organization with...
Ensysce Biosciences Issues Annual Shareholder Letter
~ FDA Breakthrough Therapy designation received for PF614-MPAR ~~ PF614-MPAR second clinical trial initiated ~~ Lead clinical candidate identified for...
TriageLogic Launches TriageIntelligence(TM) and Releases Updated Nurse Triage Handbook
JACKSONVILLE, FLORIDA / ACCESSWIRE / January 8, 2025 / TriageLogic, a leader in telehealth triage solutions, has announced two major...
Multiple Viral Threats Amplify Call for Preparedness with Broad-Spectrum Antivirals
SHELTON, CT / ACCESSWIRE / January 8, 2025 / Dr. Anil Diwan, President of NanoViricides, Inc. (NYSE American: NNVC) (the...
Vor Bio Appoints Life Sciences and Technology Investor and Entrepreneur, Mr. Erez Kalir to its Board of Directors
CAMBRIDGE, Mass., Jan. 08, 2025 (GLOBE NEWSWIRE) -- Vor Bio (Nasdaq: VOR), a clinical-stage cell and genome engineering company, today...
H1 Welcomes Former FDA Commissioner to Board of Directors, Acquires Ribbon Health, and Unveils 2025 Product Roadmap
Doubles down on its commitment to connecting the world with the right doctors and advancing healthcare innovation and inclusionNEW YORK,...
Sienna Announces Fourth Quarter 2024 Results Release Date and Conference Call
MARKHAM, Ontario, Jan. 08, 2025 (GLOBE NEWSWIRE) -- Sienna Senior Living Inc. (“Sienna” or the “Company”) (TSX: SIA) announced that...
NeurAxis Inc. Announces Strong Preliminary Unaudited Fourth Quarter 2024 Results; Revenues Increased 50% Year-Over-Year
Revenues in 4Q24 increased approximately 50% versus 4Q23Cash balance as of 12/31/24 was approximately $3.7 million CARMEL, Ind., Jan. 08,...
Outset Medical to Present at the 43rd Annual J.P. Morgan Healthcare Conference
SAN JOSE, Calif., Jan. 08, 2025 (GLOBE NEWSWIRE) -- Outset Medical, Inc. (Nasdaq: OM) (“Outset”), a medical technology company pioneering...
CirrusMD and Tendo Partner to Expand Choice and Savings for Employees and Their Dependents
CirrusMD adds Tendo CareConnect Marketplace to provide more affordable, high-quality care options for patients needing in-person careDENVER and PHILADELPHIA, Jan....
Quanta Announces IND Clearance by U.S. FDA for QTX3544, an Oral G12V-Preferring Multi-KRAS Inhibitor, and Other Pipeline Updates
– IND for QTX3544 is third for Quanta within one year – – Initiated combination portion of Phase 1 clinical...
Transcarent To Acquire Accolade
Combined company creates industry leading platform with more than 1,400 employer and payer clients, with shared focus on consumer empowerment...
Foresight Diagnostics Provides 2025 Outlook and 2024 Year in Review
- Achieved 100% revenue growth versus prior year – - Received Investigational Device Exemption approval from the FDA for the...
Oncocyte Appoints Dr. Paul Billings as Consulting Chief Medical Officer
Dr. Billings is a renowned diagnostics specialist with a history of commercializing novel assays in precision medicineWill provide key regulatory...
SeaStar Medical Begins Shipping QUELIMMUNE to a Fourth Hospital Customer
DENVER, Jan. 08, 2025 (GLOBE NEWSWIRE) -- SeaStar Medical Holding Corporation (Nasdaq: ICU), a commercial-stage medical device company developing proprietary...